Welcome to Session 3 of The Drug Development Journey.

Today. we will discuss the regulatory framework of drug development and the two-way communication we have with the regulatory authorities through rules and guidelines, regulatory submissions and consultation meetings.

We will see what is behind the Risk-benefit paradigm, and the interplay between knowledge and risk when approving a new drug for use.